Max Healthcare Institute Ltd
MAXHEALTH (NSE)

369.60

0.00
Proj. ROE (%)
16.01
Proj. P/E (x)
38.67
Proj EV / EBITDA (x)
-0.13
Proj. P/BV (x)
4.87
Proj. Revenue ( Cr.)
5,674.89

Stock View

STRONG BUY
Share on
The average score for Max Healthcare Institute Ltd stands at 6 against 4, three months back.

Max Healthcare Institute Limited is an India-based healthcare company. The Company is specialized in providing treatment for cancer care / oncology, cardiac sciences, neurosciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery and minimal access / laparoscopic surgery. Max@Home is a platform that provides health and wellness services at home and MaxLab offers pathology services to patients outside of its hospitals through a variety of channels, including third-party hospital laboratory management. It also provides treatment for Bone marrow transplant, brain stroke treatment, brain tumor surgery, breast reduction surgery, cardiac valve replacement surgery, cataract surgery, chemotherapy, coronary angioplasty, coronary artery bypass grafting, kidney transplant, laparoscopic urologic surgery, lithotripsy, liver transplant, lung transplant, pacemaker implantation and prostate laser surgery.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
369.09
100 DMA ()
365.87
200 DMA ()
368.39
52 Weeks Range
256.95
458.05
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity